Published 25 days ago • loading... • Updated 25 days ago

Lexeo Trims 15% of Workforce, Shifts Focus to Lead Cardiac Programs

Summary by biospace.com

Lexeo wants to more quickly move investigational gene therapy LX2006 into a registrational study and hopes for a potential efficacy readout in 2027.

1 Articles

All

Left

Center

Right

Lexeo wants to more quickly move investigational gene therapy LX2006 into a registrational study and hopes for a potential efficacy readout in 2027.

25 days ago

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year

Total News Sources1

Leaning Left0Leaning Right0Center0Last Updated24 days agoBias Distribution

No sources with tracked biases.

Untracked bias

Factuality

To view factuality data please Upgrade to Premium

To view ownership data please Upgrade to Vantage

biospace.com broke the news in 25 days ago on Monday, May 12, 2025.

Sources are mostly out of (0)